Chan Man Wai, Nieuwenhuis Esther A, Meijer Sybren L, Jansen Marnix, Vieth Michael, van Berge Henegouwen Mark I, Pouw R E
Gastroenterology and Hepatology, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands.
Pathology, Amsterdam UMC Locatie AMC, Amsterdam, Netherlands.
Endosc Int Open. 2025 Feb 5;13:a25097208. doi: 10.1055/a-2509-7208. eCollection 2025.
BACKGROUND AND STUDY AIMS: Endoscopic resection (ER) has proven effective and safe for T1 esophageal adenocarcinoma (EAC). However, uncertainty remains concerning risk-benefit return of esophagectomy for submucosal lesions (T1b). Surgical series in past decades have reported significant risk of lymph node metastasis (LNM) in T1b EAC, but these rates may be overestimated due to limitations in histological assessment of surgical specimens. We aimed to test this hypothesis by reassessing histological risk features in surgical specimens from T1b EAC cases with documented LNM. PATIENTS AND METHODS: A retrospective cross-sectional study (1994-2005) was conducted. Patients who underwent direct esophagectomy without prior neoadjuvant therapy for suspected T1b EAC with LNM were included. Additional tissue sections were prepared from archival tumor blocks. A consensus diagnosis on tumor depth, differentiation grade, and lymphovascular invasion (LVI) was established by a panel of experienced pathologists. RESULTS: Specific depth of submucosal invasion (sm1 to sm3) was not specified in 10 of 11 archival case sign-out reports. LVI status was not reported in seven of 11 cases. Following reassessment, one patient was found to have deep tumor invasion into the muscularis propria (T2). The remaining 10 of 11 patients exhibited deep submucosal invasion (sm2-3), with five showing one or more additional risk features (poor differentiation and/or LVI). CONCLUSIONS: Our findings highlight the potential for underestimating tumor depth of invasion and other high-risk features in surgical specimens. Despite the limited cohort size, our study confirmed a consistent high-risk histological profile across all cases. Caution is warranted when extrapolating LNM risk data from historic heterogeneous cross-sectional surgical cohorts to the modern ER era.
背景与研究目的:内镜下切除术(ER)已被证明对T1期食管腺癌(EAC)有效且安全。然而,对于黏膜下病变(T1b)行食管切除术的风险效益回报仍存在不确定性。过去几十年的外科手术系列报道显示T1b期EAC存在显著的淋巴结转移(LNM)风险,但由于手术标本组织学评估的局限性,这些发生率可能被高估。我们旨在通过重新评估有记录LNM的T1b期EAC病例手术标本的组织学风险特征来验证这一假设。 患者与方法:进行了一项回顾性横断面研究(1994 - 2005年)。纳入了因疑似T1b期EAC伴LNM而未接受新辅助治疗直接行食管切除术的患者。从存档的肿瘤组织块制备额外的组织切片。由一组经验丰富的病理学家对肿瘤深度、分化程度和脉管侵犯(LVI)达成共识诊断。 结果:11份存档病例报告中有10份未明确黏膜下浸润的具体深度(sm1至sm3)。11例中有7例未报告LVI状态。重新评估后,发现1例患者肿瘤深度侵犯至固有肌层(T2)。其余11例中的10例表现为黏膜下深层浸润(sm2 - 3),其中5例表现出一种或多种其他风险特征(低分化和/或LVI)。 结论:我们的研究结果凸显了手术标本中肿瘤浸润深度及其他高危特征可能被低估的可能性。尽管队列规模有限,但我们的研究证实了所有病例中一致的高危组织学特征。在将历史上异质性的横断面手术队列中的LNM风险数据外推至现代ER时代时应谨慎。
Dis Esophagus. 2024-6-1
United European Gastroenterol J. 2015-12
Ann Surg Oncol. 2017-11-16
World J Gastroenterol. 2013-3-7
Ann Thorac Surg. 2022-10
Histopathology. 2020-1